tirzepatide cancer risk Not 👏 A 👏 Fad ! 👏 Notice these trials are all using ?!, There are active and recently opened clinical/human trials (& more coming !) testing tirzepatide in breast-cancer populations. Why ? Tirzepatide use and the risk

10.1001/jamainternmed.2021.4804 40 LeeJ.ChangJ

GLP-1 medications change how much you eat, but your nutritional needs remain, and in some cases become more concentrated, making every meal and snack count even more

Those who have successfully implemented sustainable changesincluding regular physical activity (UK Chief Medical Officers recommend at least 150 minutes of moderate-intensity activity weekly), improved dietary patterns, and behavioural strategies for weight managementmay have better outcomes if discontinuing GLP-1 therapy

,

Protein, fiber, and water dashboard Keep the three first-month nutrition signals visible without turning the day into homework

10.1007/s12011-022-03453-7 [DOI] [PubMed] 36.Wang F, Sun N, Zeng H, et al